Goldstein Alisa M, Landi Maria Teresa, Tsang Shirley, Fraser Mary C, Munroe David J, Tucker Margaret A
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892-7236, USA.
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2208-12. doi: 10.1158/1055-9965.EPI-05-0321A.
Major risk factors for melanoma include many nevi, especially dysplastic nevi, fair pigmentation, freckling, poor tanning ability, and germ line mutations in the CDKN2A, CDK4, or MC1R genes. We evaluated the relationship between MC1R and melanoma risk in CDKN2A melanoma-prone families with extensive clinical and epidemiologic data. We studied 395 subjects from 16 American CDKN2A families. Major melanoma risk factors were assessed by clinical examination or questionnaire; MC1R was sequenced. Odds ratios were estimated by unconditional and conditional logistic regression models. We examined the distribution of MC1R variants and median ages at melanoma diagnosis in multiple primary melanoma (MPM) and single primary melanoma (SPM) patients. Presence of multiple MC1R variants was significantly associated with melanoma, even after adjustment for major melanoma risk factors. All 40 MPM patients had at least one MC1R variant; 65% of MPM patients versus only 17% of SPM patients had at least two MC1R variants (P < 0.0001). For all 69 melanoma patients combined, as well as the 40 MPM patients, there was a statistically significant decrease in median age at diagnosis as numbers of MC1R variants increased (P = 0.010 and P = 0.008, respectively). In contrast, no significant reduction in age at melanoma diagnosis was observed for SPM patients (P = 0.91). The current study suggests that the presence of multiple MC1R variants is associated with the development of multiple melanoma tumors in patients with CDKN2A mutations. Additional studies are needed to confirm these findings and to explore the mechanisms that may contribute to this relationship.
黑色素瘤的主要风险因素包括许多痣,尤其是发育异常痣、肤色白皙、雀斑、晒黑能力差以及CDKN2A、CDK4或MC1R基因的种系突变。我们利用广泛的临床和流行病学数据,评估了MC1R与CDKN2A黑色素瘤易感家族中黑色素瘤风险之间的关系。我们研究了来自16个美国CDKN2A家族的395名受试者。通过临床检查或问卷评估主要黑色素瘤风险因素;对MC1R进行测序。通过无条件和条件逻辑回归模型估计比值比。我们检查了多原发性黑色素瘤(MPM)和单原发性黑色素瘤(SPM)患者中MC1R变异的分布以及黑色素瘤诊断时的中位年龄。即使在对主要黑色素瘤风险因素进行调整后,多个MC1R变异的存在与黑色素瘤仍显著相关。所有40名MPM患者至少有一个MC1R变异;65%的MPM患者至少有两个MC1R变异,而SPM患者中这一比例仅为17%(P < 0.0001)。对于所有69名合并的黑色素瘤患者以及40名MPM患者,随着MC1R变异数量的增加,诊断时的中位年龄在统计学上显著降低(分别为P = 0.010和P = 0.008)。相比之下,未观察到SPM患者黑色素瘤诊断年龄有显著降低(P = 0.91)。当前研究表明,多个MC1R变异的存在与CDKN2A突变患者多发性黑色素瘤肿瘤的发生有关。需要进一步的研究来证实这些发现,并探索可能导致这种关系的机制。